BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26768429)

  • 1. Nestin Expression Is Associated with Poor Clinicopathological Features and Prognosis in Glioma Patients: an Association Study and Meta-analysis.
    Lv D; Lu L; Hu Z; Fei Z; Liu M; Wei L; Xu J
    Mol Neurobiol; 2017 Jan; 54(1):727-735. PubMed ID: 26768429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
    Wu B; Sun C; Feng F; Ge M; Xia L
    J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. lncRNAs as potential molecular biomarkers for the clinicopathology and prognosis of glioma: A systematic review and meta-analysis.
    Zhou Q; Liu J; Quan J; Liu W; Tan H; Li W
    Gene; 2018 Aug; 668():77-86. PubMed ID: 29777909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.
    Zhang M; Song T; Yang L; Chen R; Wu L; Yang Z; Fang J
    J Exp Clin Cancer Res; 2008 Dec; 27(1):85. PubMed ID: 19108713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical value of CD133 and nestin in patients with glioma: a population-based study.
    Dahlrot RH; Hansen S; Jensen SS; Schrøder HD; Hjelmborg J; Kristensen BW
    Int J Clin Exp Pathol; 2014; 7(7):3739-51. PubMed ID: 25120750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neural stem cell markers, nestin and musashi proteins, in the progression of human glioma: correlation of nestin with prognosis of patient survival.
    Strojnik T; Røsland GV; Sakariassen PO; Kavalar R; Lah T
    Surg Neurol; 2007 Aug; 68(2):133-43; discussion 143-4. PubMed ID: 17537489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro neurosphere formation correlates with poor survival in glioma.
    C Jayakrishnan P; H Venkat E; M Ramachandran G; K Kesavapisharady K; N Nair S; Bharathan B; Radhakrishnan N; Gopala S
    IUBMB Life; 2019 Feb; 71(2):244-253. PubMed ID: 30393962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does proximity to the subventricular zone and expression of CXCR-4 and nestin affect prognosis in high-grade glioma?
    Arzoglou V; Tsitlakidis A; Foroglou N; Polyzoidis K; Makri S; Patsalas I
    Br J Neurosurg; 2018 Dec; 32(6):614-618. PubMed ID: 30282472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of miR-21 in gliomas: comprehensive study based on meta-analysis and TCGA dataset validation.
    Jiang G; Mu J; Liu X; Peng X; Zhong F; Yuan W; Deng F; Peng X; Peng S; Zeng X
    Sci Rep; 2020 Mar; 10(1):4220. PubMed ID: 32144351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical expression of nestin in rhabdomyosarcoma: implications for clinicopathology and patient outcome.
    Glumac S; Pejic S; Kovacevic R; Dundjerovic D; Davidovic R; Ristic D; Sopta J
    Genet Mol Res; 2015 Nov; 14(4):14649-59. PubMed ID: 26600525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological and Prognostic Significance of CD133 in Glioma Patients: A Meta-Analysis.
    Han M; Guo L; Zhang Y; Huang B; Chen A; Chen W; Liu X; Sun S; Wang K; Liu A; Li X
    Mol Neurobiol; 2016 Jan; 53(1):720-727. PubMed ID: 25589004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-15a down-regulation is associated with adverse prognosis in human glioma.
    Xie T; Liu P; Chen L; Chen Z; Luo Y; Chen X; Feng Y; Luo X
    Clin Transl Oncol; 2015 Jul; 17(7):504-10. PubMed ID: 25575767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of microRNA-10b upregulation and poor prognosis in human gliomas.
    Ji Y; Wei Y; Wang J; Gong K; Zhang Y; Zuo H
    Tumour Biol; 2015 Aug; 36(8):6249-54. PubMed ID: 25773393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological significance of expression of nestin, a neural stem/progenitor cell marker, in human glioma tissue.
    Tomita T; Akimoto J; Haraoka J; Kudo M
    Brain Tumor Pathol; 2014 Jul; 31(3):162-71. PubMed ID: 24202294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and Prognostic Significance of p53 in Glioma Patients: A Meta-analysis.
    Jin Y; Xiao W; Song T; Feng G; Dai Z
    Neurochem Res; 2016 Jul; 41(7):1723-31. PubMed ID: 27038932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic Value of Nestin Expression in Adult Gliomas.
    An S; Song IH; Woo CG
    Int J Surg Pathol; 2023 Sep; 31(6):1014-1020. PubMed ID: 36168213
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictive and Prognostic Roles of Abnormal Expression of Tissue miR-125b, miR-221, and miR-222 in Glioma.
    Li X; Zheng J; Chen L; Diao H; Liu Y
    Mol Neurobiol; 2016 Jan; 53(1):577-583. PubMed ID: 25502291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of SOX2 and Nestin DNA amplification and protein expression with clinical features and overall survival in non-small cell lung cancer: A systematic review and meta-analysis.
    Li Q; Liu F; Zhang Y; Fu L; Wang C; Chen X; Guan S; Meng X
    Oncotarget; 2016 Jun; 7(23):34520-31. PubMed ID: 27150062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of the 58-kD microspherule protein (MSP58) is correlated with poor prognosis in glioma patients.
    Lin W; Li XM; Zhang J; Huang Y; Wang J; Zhang J; Jiang XF; Fei Z
    Med Oncol; 2013 Dec; 30(4):677. PubMed ID: 23996240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ki-67 is a valuable prognostic factor in gliomas: evidence from a systematic review and meta-analysis.
    Chen WJ; He DS; Tang RX; Ren FH; Chen G
    Asian Pac J Cancer Prev; 2015; 16(2):411-20. PubMed ID: 25684464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.